Skip to content
INDIASAY
Floor
PHARMA · US share of Indian pharma exports 34.61% FY25 [1]SPICES · FY25 exports US$ 4.72 bn — record volume and value [3]TEXTILES · US takes ~28% of Indian textile shipments [4]CHEMICALS · India specialty chemicals US$ 62.78 bn, 2024 [5]PHARMA · 670 USFDA-approved sites in India [1]SPICES · Chilli ~32% of India's spice export value [3]TEXTILES · Indo Count ~70% / Welspun ~60% US revenue exposure [4]CHEMICALS · Vinati Organics reports ~65% global share in IBB and ATBS [6]SPICES · Spice oils and oleoresins US$ 535.92 mn FY25 [3]PHARMA · Formulations and biologicals 75.74% of export value [2]

Record view

Product type
api
Audit evidence
No audit report on record.
Record verified
21 August 2026
Official product photograph required — Biophore India Pharmaceuticals, API manufacturing — niche and complex actives (not itemised per molecule)

Public Product Record

As published by the manufacturer
Specification
Biophore's own product listing (biophore.com/products.php) spans roughly 30 therapeutic segments and marks most entries "DMF Filed", with some marked "CEP" — but the page does not attach a DMF or CEP number to any single molecule, so no per-molecule filing is asserted here.
Packing
Not published — quoted against your specification
MOQ
Not published — quoted against your specification
Lead time
Not published — quoted against your specification
HS code
Not published — quoted against your specification
Price
Not published — quoted against your specification

Regulatory record — Active Pharmaceutical Ingredient

Verified 21 August 2026
US DMF number
Not published
US DMF status
Not published
CEP status
Not published
Letter of Access
Not published
LoA turnaround
Not published
Last US FDA inspection
Not published
Inspection outcome
Not published
Pharmacopoeia
Not published
Capacity available now
Not published
US supply active
Not published
Backward integrated
Not published
Multi-site
Not published

Audit evidence

Licensed in from the accredited body named — never an Indiasay audit

No audit report on record.

Documentation available

Released against a named consignee
  • ·Certificate of analysis for the supplied lot
  • ·Specification sheet, countersigned
  • ·Packing list and lot coding
  • ·Origin declaration
  • ·Destination-market documentation per the category guide

Released against a named consignee. Held by the manufacturer, transmitted by Indiasay.